Effect of Delmopinol on treatment of inflammation around dental implants

Effect of Delmopinol on treatment of Peri - implant mucositis: a randomised controlled clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26876

Enrollment

Registered

2015-07-14

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri - implant mucositis / Peri-implantaire mucositis

Interventions

- Mechanical debridement alone (along with placebo) - Mechanical debridement along with Delmopinol mouthrinse - Mechanical debridement along with Chlorhexidine mouthrinse

Eligibility

Inclusion criteria

Inclusion criteria: - Human adult patients with at least one screw type dental implant - Bleeding on probing and / pus (< 0.25 N probing pressure)around at least one dental implant - Implant in function at least 1 year, no radiographic boneloss beyond 2 mm compared to baseline radiograph - Informed consent obtained after verbal and written information by investigator.

Exclusion criteria

Exclusion criteria: - Osseointegrated dental implant with more than 2 mm boneloss as identified by comparing current radiograph with radiograph completed at time of prosthetic restoration. - Patients smoking more than 20 sig/day -Uncontrolled Diabetes Mellitus - Untreated periodontitis - Antibiotic/antiinflammatory use within last one month before start of study. -Pregnancy and lactation - psychiatric disorders

Design outcomes

Primary

Measure	Time frame
- Change in bleeding on Probing	—

Secondary

Measure	Time frame
- Plaque index - Pocket probing depth -Microbiological changes	—

Contacts

Public ContactJ. Philip

kamer 3n 43, Orale functieleer en rest tandheelkunde, ACTA

j.philip@acta.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)